February 23, 2017 4:56 AM ET

Diversified Consumer Services

Company Overview of University of Rochester

Company Overview

University of Rochester is an educational institution offering degree programs at the bachelors, masters, and doctoral level. The schools of the university include William E. Simon Graduate School of Business Administration; Margaret Warner Graduate School of Education and Human Development; School of Medicine and Dentistry; School of Nursing; Strong Memorial Hospital; Golisano Children's Hospital; Eastman Dental Center; Laboratory for Laser Energetic; and Center for Optoelectronics and Imaging. University of Rochester was established in 1850 and is based in Rochester, New York. The university has endowment assets worth $1298 million.

601 Elmwood Ave

Rochester, NY 14642-0001

United States

Founded in 1851





Key Executives for University of Rochester

Age: 66
Professor of Finance and Statistics
Age: 66
Compensation as of Fiscal Year 2016.

University of Rochester Key Developments

University of Rochester Appoints Elizabeth Stauderman as Vice President for Communications to Replace Bill Murphy

Elizabeth Stauderman, who has been chief communications officer at Yale University, will be the new vice president for communications at the University of Rochester. Stauderman, who will begin full time at UR in August, will fill the vacancy left by Bill Murphy, who is retiring. He has served as chief spokesman for the university since 2006. Stauderman, 53, has spent most of her professional career at Yale, after graduating from that university with a bachelor's in history in 1983. Previously, Stauderman held such positions at Yale as deputy chief communications officer, associate dean for communications and strategy at the Yale School of Management and director of public affairs for Yale Law School.

Panther Biotechnology, Inc. Enters into Global License Agreement with University of Rochester

Panther Biotechnology Inc. announced that it has entered into an exclusive global license agreement with the University of Rochester. Under the terms of the agreement, Panther has licensed from the University of Rochester, the rights to develop and commercialize a first in class new chemical entity with demonstrated powerful anti-leukemia activity. The licensed compound, called TDZD-8, is a small molecule engineered to kill leukemic stem cells. TDZD-8 has demonstrated broad and selective in vitro activity against many different types of leukemia. In addition, TDZD-8 has no significant toxicity in normal hematopoietic stem cells. TDZD-8 is a kinase inhibitor and induces oxidative stress, causing its striking ability to induce the leukemia cells to die after less than 2 hours of exposure to the drug.

Similar Private Companies By Industry

Company Name Region
1-800-Dryclean, LLC United States
1-800-PHONESEX United States
125 Max Drycleaning Center LLC United States
180 Skills LLC United States
19Pencils, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University of Rochester, please visit www.rochester.edu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.